Furthermore, the CCL20-CCR6 axis recruited circulating regulatory T cells into tumor microenvironment, resulting in tumor progression and poor prognosis in patients with hepatocellular carcinoma [38]. This evidence concerns the gene CCL20 and hepatocellular carcinoma.